NCT02117752View on ClinicalTrials.gov

Dermal Tolerability of Dapsone Gel in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

237

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

dapsone gel

Patches containing dapsone gel will be applied to the skin.

DRUG

dapsone gel vehicle

Patches containing dapsone gel vehicle will be applied to the skin.

DRUG

sodium lauryl sulfate

Patches containing sodium lauryl sulfate (Positive Control) will be applied to the skin.

DRUG

Normal saline

Patches containing normal saline (Negative Control) will be applied to the skin.

Trial Locations (1)

Unknown

Fair Lawn

Sponsors

Lead Sponsor

Almirall, S.A.

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Almirall, S.A.

INDUSTRY

NCT02117752 - Dermal Tolerability of Dapsone Gel in Healthy Volunteers | Biotech Hunter | Biotech Hunter